Medical therapies in myasthenia gravis

Chest Surgery Clinics of North America

Volumn 11, Issue 2, 2001, Pages 329-336

  Younger, D S ^a   Raksadawan, N ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE;

COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; HUMAN; MORTALITY; MYASTHENIA GRAVIS; NEEDLE BIOPSY; NEUROMUSCULAR DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

HUMANS; MYASTHENIA GRAVIS; THYMUS GLAND;

EID: 0034995020     PISSN: 10523359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Relevance of experimental models of myasthenia gravis to human acquired myasthenia gravis
2. Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patients
3. Long-term maintenance ACTH therapy in myasthenia gravis
4. Aspects of the natural history of myasthenia gravis: Crisis and death
5. Immunosuppressive treatment: Their efficacy on myasthenia gravis patient's outcome and on the natural history of the disease
6. Lambert lecture: Immunotherapy in neuromuscular disorders: Current and future strategies
7. Treatment of experimental myasthenia gravis with cyclosporine A
8. Effect of adrenocorticotrophic hormone (ACTH) and cortisone administration in patients with myasthenia gravis
9. Myasthenia gravis: Stimulation of anti-receptor autoantibodies by autoreactive T cell lines
10. Thymectomy for myasthenia gravis: Analysis of the controversies regarding technique and results
11. Myasthenia gravis: Recommendations for clinical research standards
12. "Maximal" thymectomy for myasthenia gravis: Results
13. "Maximal" thymectomy for myasthenia gravis: Surgical anatomy and operative technique
14. Treatment of myasthenia gravis with prednisone
15. Cellular and molecular mechanisms of cyclosporine nephrotoxicity
16. Myasthenia gravis with thymoma
17. Long-term administration of corticosteriods in myasthenia gravis
18. Immunosuppressive drugs: Azathioprine in the treatment of myasthenia gravis
19. The thymus in myasthenia gravis: Changes thypical for the human disease are absent in experiemental autoimmune myasthenia gravis of the Lewis rat
20. The treatment of severe myasthenia gravis with immunosuppressive agents
21. Effects of immunosuppressive drugs (azathioprine)
22. Clinical evaluation of ACTH in myasthenia gravis
23. Thymic abnormalities: Antigen or antibody? Response to thymectomy in myasthenia gravis
24. Effects of cyclosporine on human T cell activation
25. Cyclosporine A vs azathioprine in the treatment of myasthenia gravis: Final results of a randomized, controlled double-blind trial
26. Transplantation of myasthenia gravis thymus to SCID mice
27. Effects of cortisone in certain neuromuscular disorders
28. Myasthenia gravis: Effect of treatment with anterior pituitary extract
29. Steps in the generation of autoantibodies
30. A clinical therapeutic trial of cyclosporine in myasthenia gravis
31. Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis
32. Effects of adrenocorticotrophic hormone on neuromuscular function in patients with myasthenia gravis
33. Effects of adrenocorticotrophic hormone on neuromuscular function in patients with myasthenia gravis
34. Benefit from alternate day prednisone in myasthenia gravis
35. Pathologisch-anatomischer beitrag zur Erb'schen krancheit (myasthenia gravis)
36. Myasthenia gravis: Historical perspectives and overview